| Stuart Kent Harrell, OD | |
|
2004 Cr 540-a, Lakeland, FL 33813 | |
| (863) 294-3504 | |
| (866) 522-3607 |
| Full Name | Stuart Kent Harrell |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 35 Years |
| Location | 2004 Cr 540-a, Lakeland, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134212145 | NPI | - | NPPES |
| 621353700 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | OPC2359 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anthony Schaffer Od Mba Pl | 7315023256 | 2 |
News Archive
Clinical engineers can help fill a crucial role in today's heath care industry by providing the technical expertise needed to manage the health care technology, such as X-rays, CT scans and MRIs, that clinicians use to help make life-saving decisions for their patients.
Myrexis, Inc., a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today presented key preclinical findings of the Company's novel oral anti-interferon, MPI-0485520, at the 74th Annual Scientific Meeting of the American College of Rheumatology/Association of Rheumatology Health Professionals, in Atlanta, Georgia.
A team led by scientists at The Scripps Research Institute has been awarded $2.1 million by the Department of Defense Congressionally Directed Medical Research Programs to study several compounds with the potential to greatly improve the quality of life for those with amyotrophic lateral sclerosis (ALS) or Lou Gehrig's disease.
The identification of a gene expression profile using microarray technology may help clinicians better determine the prognosis of patients with advanced stage ovarian cancer and may eventually help provide targeted therapies for this hard-to-treat disease, according to a study led by investigators at Beth Israel Deaconess Medical Center (BIDMC).
› Verified 4 days ago
| Provider Name | Barry M Gaffney Od Pa |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1962568451 PECOS PAC ID: 2264433937 Enrollment ID: O20070123000461 |
News Archive
Clinical engineers can help fill a crucial role in today's heath care industry by providing the technical expertise needed to manage the health care technology, such as X-rays, CT scans and MRIs, that clinicians use to help make life-saving decisions for their patients.
Myrexis, Inc., a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today presented key preclinical findings of the Company's novel oral anti-interferon, MPI-0485520, at the 74th Annual Scientific Meeting of the American College of Rheumatology/Association of Rheumatology Health Professionals, in Atlanta, Georgia.
A team led by scientists at The Scripps Research Institute has been awarded $2.1 million by the Department of Defense Congressionally Directed Medical Research Programs to study several compounds with the potential to greatly improve the quality of life for those with amyotrophic lateral sclerosis (ALS) or Lou Gehrig's disease.
The identification of a gene expression profile using microarray technology may help clinicians better determine the prognosis of patients with advanced stage ovarian cancer and may eventually help provide targeted therapies for this hard-to-treat disease, according to a study led by investigators at Beth Israel Deaconess Medical Center (BIDMC).
› Verified 4 days ago
| Provider Name | Anthony Schaffer Od Mba Pl |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1750579850 PECOS PAC ID: 7315023256 Enrollment ID: O20080318000685 |
News Archive
Clinical engineers can help fill a crucial role in today's heath care industry by providing the technical expertise needed to manage the health care technology, such as X-rays, CT scans and MRIs, that clinicians use to help make life-saving decisions for their patients.
Myrexis, Inc., a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today presented key preclinical findings of the Company's novel oral anti-interferon, MPI-0485520, at the 74th Annual Scientific Meeting of the American College of Rheumatology/Association of Rheumatology Health Professionals, in Atlanta, Georgia.
A team led by scientists at The Scripps Research Institute has been awarded $2.1 million by the Department of Defense Congressionally Directed Medical Research Programs to study several compounds with the potential to greatly improve the quality of life for those with amyotrophic lateral sclerosis (ALS) or Lou Gehrig's disease.
The identification of a gene expression profile using microarray technology may help clinicians better determine the prognosis of patients with advanced stage ovarian cancer and may eventually help provide targeted therapies for this hard-to-treat disease, according to a study led by investigators at Beth Israel Deaconess Medical Center (BIDMC).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stuart Kent Harrell, OD 407 Avenue K Se, Winter Haven, FL 33880-4126 Ph: (863) 294-3504 | Stuart Kent Harrell, OD 2004 Cr 540-a, Lakeland, FL 33813 Ph: (863) 294-3504 |
News Archive
Clinical engineers can help fill a crucial role in today's heath care industry by providing the technical expertise needed to manage the health care technology, such as X-rays, CT scans and MRIs, that clinicians use to help make life-saving decisions for their patients.
Myrexis, Inc., a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today presented key preclinical findings of the Company's novel oral anti-interferon, MPI-0485520, at the 74th Annual Scientific Meeting of the American College of Rheumatology/Association of Rheumatology Health Professionals, in Atlanta, Georgia.
A team led by scientists at The Scripps Research Institute has been awarded $2.1 million by the Department of Defense Congressionally Directed Medical Research Programs to study several compounds with the potential to greatly improve the quality of life for those with amyotrophic lateral sclerosis (ALS) or Lou Gehrig's disease.
The identification of a gene expression profile using microarray technology may help clinicians better determine the prognosis of patients with advanced stage ovarian cancer and may eventually help provide targeted therapies for this hard-to-treat disease, according to a study led by investigators at Beth Israel Deaconess Medical Center (BIDMC).
› Verified 4 days ago
Eye Doctors Optical Outlets Pa Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3654 Harden Blvd, Lakeland, FL 33803 Phone: 813-885-3937 | |
Phillips Salomon & Parrish Pa Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1251 Lakeland Hills Blvd, Lakeland, FL 33805 Phone: 863-688-1545 Fax: 863-595-0927 | |
Tincy Thomas, O.D Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2004 Cr 540-a, Lakeland, FL 33813 Phone: 863-937-4515 | |
Mary W Frates, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1600 Lakeland Hills Blvd, Lakeland, FL 33805 Phone: 863-680-7000 Fax: 866-264-8519 | |
Dr. Marion S. Lewis & Associates Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5535 Kings Mont Dr, Lakeland, FL 33813 Phone: 863-648-4770 Fax: 888-873-4425 | |
Ryan M Odil, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1400 S Florida Ave, Lakeland, FL 33803 Phone: 863-250-5553 | |
Dr. Marion Stewart Lewis, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 3615 S Florida Ave, Lakeland, FL 33803 Phone: 863-940-2091 Fax: 863-940-4764 |